Oscar Millet (CEO)
Oscar is doctor in organic chemistry and chemical engineer. He currently is the Group Leader at the Precision Medicine and Metabolism Laboratory of the CIC bioGUNE, has in-depth expertise in the use of nuclear magnetic resonance (NMR) for the study of biologically relevant proteins and enzymes.
Joaquín Castilla (CSO)
Joaquín is doctor in pharmacy and researcher with extensive expertise in prion diseases. He currently is the Group Leader at the Prion Laboratory of the CIC bioGUNE, has in-depth experience in prion diseases, preclinical studies and animal models.
Cristina Garrido (COO)
Cristina holds a bachelor’s degree in Pharmacy and a master’s degree in Monitoring and Management of clinical studies. She has more than 13 years of experience in the industry, having participated in clinical developments in different therapeutic areas. She leads the operations of the company focused on the execution of Phase I-II clinical trials.
Hasier Eraña (Project manager)
Hasier obtained a PhD in Molecular Biology and Biomedicine. He worked in the same institute as post-doctoral researcher until 2016, and in 2017, he joined Atlas to develop the Prion disease pipeline.
Jorge Moreno (Staff scientist)
Jorge performed his PhD at CIC bioGUNE in Neurosciences. In ATLAS, he has continued his work on the development of therapeutic strategies for prion diseases and as responsible of most of the studies in animal models.
Alain Ibañez de Opakua (Staff scientist)
Alain holds a dual academic background, with a bachelor’s degree in Biochemistry and a degree in Computer Engineering. He completed his PhD at the University of the Basque Country (UPV/EHU), followed by postdoctoral research at CIC bioGUNE before advancing his career at prestigious German institutions including DZNE and MPI. Alain’s expertise lies at the intersection of structural biology and data analysis, complemented by extensive hands-on experience with various biochemical and biophysical techniques.
Mireia Pujals (Operations Manager)
Mireia obtained her PhD in Biomedicine from the University of Barcelona. After completing a master’s degree in Clinical Trial Monitoring, she joined ATLAS as an Operations Manager in 2024. She brings her scientific background and clinical research expertise to support the company’s ongoing trial management and strategic operations.
Jon Gil Martínez (Ph. D. student)
Jon Gil-Martínez graduated in Biochemistry and Molecular Biology from the University of the Basque Country (2018) and earned his Master’s in Biomedicine from the University of Barcelona (2019). After working as a Laboratory Technician at CIC bioGUNE, he developed his doctoral thesis there from 2020 to 2024. During this time, he gained expertise in metabolomics, crystallography, and CRISPR/Cas9-modified cellular models. He specializes in developing these advanced cellular models.
Riccardo Scarin (Ph. D. student)
Riccardo obtained a Master Degree in Pharmaceutical Biotechnology at University of Padua. He is currently doing a PhD in Atlas Molecular Pharma, focusing on the characterization of ligand-protein interaction with the aim of developing a Pharmacological Chaperon for the treatment of Tyrosinemia type I.
Sarah Kratzwald (Ph. D. student)
Sarah is pursuing her PhD at ATLAS Molecular Pharma located at the CICbioGUNE in Bilbao, Spain as part of the European Network on the Supramolecular Chemistry of Carbohydrates (ENSCC). She earned her Bachelor’s degree in Chemistry from the University of Vienna and holds Master’s degrees in Technical Chemistry from the Vienna University of Technology and Molecular Biology from the University of Vienna. Her academic and professional journey focuses on organic synthesis, biochemistry, and protein NMR spectroscopy.